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Abstract
Introduction: Langerhans cells (LCs) are a very important part of the skin immune system. 
Materials and Methods: Skin biopsies taken from 13 women after the removal of vulvar squamous cell carcinoma (SCC) who
had not been treated earlier for any vulvar diseases were investigated. The control group consisted of 12 women who under-
went a plastic surgical operation of the vulva region. Immunohistochemical staining was performed on formalin-fixed,paraf-
fin-embedded tissuessamples using antihuman CD1a antibody (NCL-CD1a-235, Novocastra).
Results: This study showed a large decrease in LCs in vulvar SCC. 
Conclusions: It is postulated that the reduction in the number of LCs may be one of the reasons for a higher tendency of car-
cinogenesis in the vulvar region. Their role as a main element of the skin immune system in the initiation of this process
needs further investigation. It is possible that research on LCs in the skin will cast a new light on their role and even con-
tribute to the prophylaxis and treatment of skin and mucosa carcinomas. 
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ORIGINAL ARTICLE
INTRODUCTION
Langerhans cells (LCs) constitute 3–8% of all
epithelial cells. The largest number is found in the basal
and squamous layers. They are not present in the cor-
neous layer. LCs are dendritic cells and they specialize
in antigen presentation [14, 16]. Researchers have
recently turned their attention to the relationship
between LCs and carcinoma transformations in the skin.
In the past, LCs were determined by means of the reac-
tion with S-100 antigen. It turned out that this antigen
was also present on other cells, so the results of the
examinations were not precise, and even contradictory
[1, 13]. At present, CD1a molecule and the positive
reaction with the above-mentioned glycoprotein are
basic to the evaluation of LCs [6]. Authors have also
reported a diminishing and impairment of LC function
as a result of immunosuppressive treatment, including
applied locally corticosteroids and excessive UV radia-
tion, especially UVB, which can subsequently lead to
the development of skin carcinoma [15, 23]. It is pro-
posed that LCs play a role in host resistance to malig-
nant neoplasmas in the epidermis [8]. The aim of this




We investigated skin biopsies taken from 13 women
with vulvar SCC who had not been treated for any vul-
var diseases earlier (mean age: 61.1±11.7 years). The
patients underwent vulvectomy. The cases of SCC rep-
resented a well and moderate histopathological grade,
with characteristic foci of keratinization. The adjacent
tissues did not show pathological changes. The control
group consisted of normal vulvar skin tissue obtained
from surgical specimens from 12 women (mean age:57.3±11.2) who underwent a plastic surgical operation
of the vulva region. The regional ethics committee
approved the project. All enrolled subjects were
informed about the purposes and methods of the
research and gave their written consent.
Immunohistochemistry
Immunohistochemical staining was performed on
formalin-fixed,paraffin-embedded tissuessamples using
antihuman CD1a antibody (NCL-CD1a-235, Novo-
castra). This antibody recognizes the human CD1a cell
surface glycoprotein, a 43–49 kDa molecule expressed
in association with β2 microglobulin. CD1a is expressed
strongly by cortical thymocytes, LCs in the epidermis,
dendritic cells in dermis, and also by LCs of mucosa of
the tonsil.
The paraffin-embedded sections of tumor were
deparaffinized, rehydrated, and heat-treated for citrate
microwave antigen retrieval in 10 mM citrate buffer, pH
6.0, at 350 Wfor 15 min and then cooled to room tem-
perature. Sections werethen blocked for peroxidases in
0.3% H2O2 in methanol for 30 min, and incubated with
the primary antibody anti-CD1a (dilution 1:50) for 30
min at room temperature in a humidity chamber. For
detection, a Dako Envision System HRP with DAB
staining and hematoxylin counterstaining was used.For
a negative control, the slides were stained with the omis-
sion of the primary antibody. For a positive control, tis-
sues of mucosa of the tonsil were used. 
Evaluation of LCs
Immunohistochemical staining revealed that LCs
exhibited characteristic processes. The number of LCs
in each of the cases was estimated as the number of cells
calculated per 10 high-power fields (HPFs) at 400×
magnification.
Statistics 
The examined group and the control group were
compared by the Mann-Whitney U-test.
RESULTS
Immunohistochemical staining revealed that LCs
exhibited cytoplasmatic characteristic processes. The
number of LCs in SCC was very low compared with the
control group (p<0.001; Table 1), the mean number of
LCs being 0.85/10 HPFs (range: 0.0–2.0; Fig. 1). The
mean number of LCs in the control tissue was 11.58/10
HPFs (range: 6.0–15.0; Fig. 2). 
DISCUSSION
This study suggests that the decreased number of
LCs may be directly connected with the process of car-
cinogenesis in the vulvar regions. The vulvar mucosa can
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Table 1. The number of Langerhans cells in squamous cell carcinoma and the control group
Groups Number Range Median Mean SD SEM p
SCC 13 0.0–2.0 1.0 0.85 0.90 0.25 <0.001
Control 12 6.0–15.0 12.0 11.58 2.81 0.81
Fig. 1. The squamous cell carcinoma – the decreased number of
Langerhans cells. Immunohistochemical staining with anti
CD1a antibody, Dako Envision System HRP DAB, hematoxylin
counterstaining, ×400.
Fig. 2. The skin section of control tissue without pathological
changes. Note a few LC with characteristic proccesses.
Immunohistochemical staining with anti CD1a antibody, Dako
Envision System HRP DAB, hematoxylin counterstaining, ×400.be a starting point for SCC. In this region, carcinogene-
sis seems to be connected with infections and inflamma-
tion processes, which in turn may be caused by mechan-
ical traumas (9). This may cause impairment of the
skin’s immune system, which can lead to carcinogenic
transformation. Moreover, it is worth underlining that
in vulvar lichen sclerosus, oxidative stress plays a signifi-
cant role in involved tissue. Oxidative damage to lipids,
DNA, and proteins may contribute to oxidative tissue
injury, which may also lead to carcinogenesis [20].
Nitrative damage to nucleic acids also plays an impor-
tant role in carcinogenesus. This occurs during inflam-
matory processes when reactive nitrogen species, such
as peroxynitrite, nitroxyl, and nitrogen dioxide, are gen-
erated. This may lead to the accumulation of mutagenic
DNA lesions and p53 in damaged epithelium and carci-
noma connected with inflammation [4, 12]. 
The connection between inflammation and cancer
caused by chronic infection has been recognized in
numerous solid tumors. Helicobacter pylori-induced gas-
tritis leading to gastric cancer, inflammatory bowel dis-
ease leading to colorectal cancer, inflammation in the
pancreas, chronic viral hepatitis leading to liver cancer,
and oral lichen planus leading to squamous oral cancer
are among the examples [4, 5, 7, 12]. 
It is believed that vulvar SCC may be divided into
two groups: a group originating from vulvar intraepithe-
lial neoplasia, in which human papilloma virus (HPV)
infection may cause carcinogenesis, and an SCC group
which is connected with chronic vulvar dystrophy [3, 17].
Various dystrophic lesions of the vulvar epithelium were
found in about 70–80% of SCC surrounding tissues [19]. 
Some authors also raise a question of the long-term
application of steroid ointments in vulvar inflammation
processes and the possibility of it leading to latent HPV
infection. This may indicate that vulvar dystrophy is
a process which can lead to carcinoma development.
Other authors divide vulvar SCC into HPV-dependent
and HPV-independent [6, 18, 21].
Many investigations have proved that UV radiation,
especially UVB, has a similar influence on decreasing
the LC number in the skin in a dose-dependent manner
[22]. Interestingly, some studies also exhibited morpho-
logical changes of LCs (deformation of the dendritic
processes and alterations of the Birbeck granules) [1,
24]. The immunosuppressive activity of UV radiation is
caused by cytokines secreted by epithelial cells, mainly
interleukin IL-10. This influences the skin’s immune sys-
tem through lowering the secretion of other cytokines
and inhibiting antigen presentation by LCs. At the same
time, IL-10 influences LCs, transforming them into
inactive forms [2, 11].
In patients who underwent renal transplantation,
impairment of the immune system function was con-
nected with the development of skin carcinoma. An
increased frequency of skin carcinoma, mainly SCC, was
found in patients after renal transplantation subjected
to immunosuppression [10]. 
Our findings clearly show a large decrease in or
absence of LCs in vulvar SCC. The number of LCs was
significantly decreased in the epidermis in Bowen’s dis-
ease [6]. Investigations indicate a decrease in LC num-
ber in the epithelium of the inner surface of the pre-
puce, which, according to the researchers, together with
infections and increased incidence of traumas in this
region, may trigger carcinogenesis [25].
In SCC, very few CD1-positive LCs were concen-
trated at the periphery of neoplastic epithelium, while
they were absent in the central part of the tumor [24].
The role of LCs as a main element of the
skin’s immune system in the initiation of the carcino-
genic process needs further investigation. It is possible
that research on LCs in the skin will cast a new light on
their role and even contribute to the prophylaxis and
treatment of skin and mucosa carcinomas. 
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